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ABSTRACT 
Purpose: This study aimed to explore the views of Malaysian healthcare professionals (HCPs) 
on the roles of various stakeholders who were involved in making decisions about prostate 
cancer treatment.  
Method: Four in-depth interviews and three focus group discussions were conducted with 
HCPs from government and private hospitals in Malaysia between December 2012 and 
March 2013. HCPs consisted of private urologists (n=4), government urologists (n=6), 
urology trainees (n=5), government policy maker (n=1) and oncologists (n=3). There were 16 
male and three female participants. Trained researchers used a topic guide to guide the 
interviews which were audio-recorded, transcribed verbatim, checked and managed with 
Nvivo 10 software. Thematic approach was used to analyse the data.  
Result: Three parties were involved in the decision making process: HCPs, patients and 
family. Patients who did not understand prostate cancer and its treatment had difficulty in 
making decisions. These patients tended to leave the decision to the HCPs. Some patients 
made their own treatment decision. Some patients avoid asking too many questions to avoid 
the possibility of being influenced towards one option by their HCP. HCPs would leave the 
final say to the patient because of three reasons: to avoid patients’ regret (“patient will not be 
happy at the end of the day”); wanting the patient to “balance what they wanted and what was 
the reality of each option”; and knowing there was no single best treatment option. The 
family members, especially children, made the decision for some patients. This may be due to 
Malaysia’s close-knit family culture where patients were concerned about their children’s 
emotions. While some patients were able to make their own decisions for non-invasive 
treatment (e.g. hormonal treatment), they would like to involve their family if they were 
considering surgery. HCPs observed that patients rarely involved their wives in decision 
making.  
Conclusion: Decision making during prostate cancer treatment involves three parties; HCP, 
patient and family. The decisional roles depend on the patients personal preferences, 
understanding of the illness, and the family dynamics. 
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